SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fortis Healthcare informs about disclosure

01 Jun 2023 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Fortis Healthcare has informed that the Registrar of Companies has, on May 31, 2023, approved the application for change in name of SRL, a material subsidiary of Fortis Healthcare, to Agilus Diagnostics. A new Certificate of Incorporation has been issued by the ROC confirming the change in name to 'Agilus Diagnostics Limited'. The above is in furtherance of the efforts undertaken by Agilus Diagnostics over the last few years towards rebranding and adoption of a new brand identity of- 'agilus diagnostics'.

The above information is a part of company’s filings submitted to BSE.

Fortis Healthcare Share Price

972.70 20.60 (2.16%)
11-May-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×